SLS - SELLAS Life Sciences Group Inc
IEX Last Trade
1.29
-0.010 -0.775%
Share volume: 535,683
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.30
-0.01
-0.77%
Summary score
19%
Profitability
18%
Dept financing
15%
Liquidity
44%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2018 - 31-Dec-2022
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-90.68%
Return on assets
-22.92%
Return on sales
-291.54%
Return on invested capital
-16.13%
Total debt ratio
50.95%
Debt ratio change over timeo
-1.1%
Current Ratio
2.86%
Quick Ratio
2.86%
Cash Position Ratio
2.54%
Short-term ratios 31-Dec-2021 - 31-Dec-2022
The data are presented for the financials results of the quarters of the last year.
Return on equity
-175.98%
Return on assets
-32.7%
Return on sales
-673.5%
Return on invested capital
120.9%
Total debt ratio
62.61%
Debt ratio change over timeo
-0.38%
Current Ratio
1.74%
Quick Ratio
1.74%
Cash Position Ratio
1.59%
Last quarter ratios 31-Dec-2022
The data are presented for the financials results of the last quarter.
Return on equity
-188.02%
Return on assets
-45.1%
Return on sales
0%
Return on invested capital
73.99%
Total debt ratio
76.84%
Debt ratio change over time
0.04%
Current Ratio
1.14%
Quick Ratio
1.14%
Cash Position Ratio
1.1%
Performance ratios (change over 4 years) 31-Dec-2018 - 31-Dec-2022
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-96.54%
Return on assets
-99.59%
Return on sales
-114.85%
Return on invested capital
-30.3%
Total debt ratio
-109.63%
Debt ratio change over time
-1.1%
Current Ratio
-1.44%
Quick Ratio
-1.44%
Cash Position Ratio
-1.35%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SLS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -90.68% | 1.67% | 33.68% | 7.86% |
| Return on assets | -22.92% | 3.5% | 3.76% | 5.92% |
| Return on sales | -291.54% | 33.1% | 37.17% | 40.11% |
| Return on invested capital | -16.13% | 4.61% | 6.91% | 20.46% |
| Profitability | 0% | 42% | 72% | 81% |
| Total debt ratio | 50.95% | 96.79% | 87.33% | 27.76% |
| Debt ratio change over time | -1.1% | 272.38% | 14.08% | 1.19% |
| Dept financing | 13% | 50% | 24% | 7% |
| Current Ratio | 1.74% | 0.89% | 1.52% | 5.07% |
| Quick Ratio | 1.74% | 0.78% | 1.18% | 4.32% |
| Cash Position Ratio | 1.59% | 0.3% | 0.62% | 2.44% |
| Liquididy | 64% | 22% | 30% | 67% |
| Short-term ratios | SLS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -175.98% | 18.14% | 79.6% | 5.11% |
| Return on assets | -32.7% | 3.34% | 3.87% | 4.53% |
| Return on sales | -673.5% | 32.51% | 36.49% | 40.56% |
| Return on invested capital | 120.9% | 3.63% | 6.13% | 11.61% |
| Profitability | 25% | 45% | 70% | 54% |
| Total debt ratio | 62.61% | 88.66% | 95.75% | 23.34% |
| Debt ratio change over time | -0.38% | 34.32% | 15.38% | 1.05% |
| Dept financing | 16% | 48% | 36% | 7% |
| Current Ratio | 1.74% | 0.89% | 1.52% | 5.07% |
| Quick Ratio | 1.74% | 0.78% | 1.18% | 4.32% |
| Cash Position Ratio | 1.59% | 0.3% | 0.62% | 2.44% |
| Liquididy | 35% | 12% | 21% | 75% |